ALT-formulated hormone replacement therapies

ALT配制的激素替代疗法

Report date: 2022/12/17 17:10:19
NME

Base Information

Drug NameALT-formulated hormone replacement therapies
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSancilio
China Registration ClassN/A

Develop Information

Active CompaniesSancilio
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A